Dorian Bevec

3.4k total citations
62 papers, 2.9k citations indexed

About

Dorian Bevec is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Dorian Bevec has authored 62 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Immunology and 15 papers in Virology. Recurrent topics in Dorian Bevec's work include HIV Research and Treatment (15 papers), Polyamine Metabolism and Applications (14 papers) and Mast cells and histamine (11 papers). Dorian Bevec is often cited by papers focused on HIV Research and Treatment (15 papers), Polyamine Metabolism and Applications (14 papers) and Mast cells and histamine (11 papers). Dorian Bevec collaborates with scholars based in Austria, Germany and United States. Dorian Bevec's co-authors include Joachim Hauber, Herbert Jaksche, Peter Valent, Marika Dobrovnik, Klaus Lechner, Olaf Rosorius, Michèle Himmelspach, Ernst Böhnlein, Peter Bettelheim and Friedrich Krätzer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dorian Bevec

61 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorian Bevec Austria 32 1.4k 1.1k 442 301 286 62 2.9k
Patricia E. Rao United States 27 1.0k 0.7× 2.2k 2.1× 285 0.6× 789 2.6× 597 2.1× 53 4.0k
Kevin L. Holmes United States 32 998 0.7× 1.8k 1.7× 311 0.7× 109 0.4× 99 0.3× 68 3.2k
Sheryl Brown‐Shimer United States 14 1.4k 0.9× 972 0.9× 493 1.1× 119 0.4× 99 0.3× 18 2.7k
Ludger Ständker Germany 30 1.3k 0.9× 469 0.4× 265 0.6× 183 0.6× 138 0.5× 94 2.6k
Daniel C. Hoessli Switzerland 26 1.6k 1.1× 885 0.8× 111 0.3× 208 0.7× 300 1.0× 92 2.7k
Jacques Thèze France 36 1.1k 0.8× 2.9k 2.8× 772 1.7× 181 0.6× 148 0.5× 194 4.4k
R. Kurrle Germany 25 709 0.5× 1.3k 1.2× 540 1.2× 113 0.4× 109 0.4× 102 2.4k
Vincent J. Merluzzi United States 17 558 0.4× 585 0.6× 554 1.3× 335 1.1× 125 0.4× 32 2.2k
Michael K. Hoffmann United States 35 655 0.5× 2.6k 2.5× 304 0.7× 135 0.4× 129 0.5× 105 3.6k
Thomas Hoffman United States 25 1.0k 0.7× 1.5k 1.4× 191 0.4× 105 0.3× 201 0.7× 74 2.9k

Countries citing papers authored by Dorian Bevec

Since Specialization
Citations

This map shows the geographic impact of Dorian Bevec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorian Bevec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorian Bevec more than expected).

Fields of papers citing papers by Dorian Bevec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorian Bevec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorian Bevec. The network helps show where Dorian Bevec may publish in the future.

Co-authorship network of co-authors of Dorian Bevec

This figure shows the co-authorship network connecting the top 25 collaborators of Dorian Bevec. A scholar is included among the top collaborators of Dorian Bevec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorian Bevec. Dorian Bevec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matteo, Tiziana Di, et al.. (2014). Graph Theory Enables Drug Repurposing – How a Mathematical Model Can Drive the Discovery of Hidden Mechanisms of Action. PLoS ONE. 9(1). e84912–e84912. 27 indexed citations
2.
Prasse, Antje, Gernot Zissel, Niklas Lützen, et al.. (2010). Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 182(4). 540–548. 115 indexed citations
3.
Sielaff, Frank, Manuel E. Than, Dorian Bevec, Iris Lindberg, & Torsten Steinmetzer. (2010). New furin inhibitors based on weakly basic amidinohydrazones. Bioorganic & Medicinal Chemistry Letters. 21(2). 836–840. 26 indexed citations
4.
Leuchte, Hanno, et al.. (2009). Preserved pulmonary vasodilative properties of aerosolized brain natriuretic peptide. Pulmonary Pharmacology & Therapeutics. 22(6). 548–553. 1 indexed citations
5.
Specht, Sabine, Ilona Hauber, Joachim Hauber, et al.. (2008). The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria—inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase. Parasitology Research. 102(6). 1177–1184. 23 indexed citations
6.
Leuchte, Hanno, R Baumgärtner, Dorian Bevec, et al.. (2008). Inhalation of vasoactive intestinal peptide in pulmonary hypertension. European Respiratory Journal. 32(5). 1289–1294. 85 indexed citations
7.
Schäfer, Birgit, et al.. (2006). Inhibition of Multidrug‐Resistant HIV‐1 by Interference with Cellular S‐adenosylmethionine Decarboxylase Activity. The Journal of Infectious Diseases. 194(6). 740–750. 20 indexed citations
8.
Hauber, Ilona, Dorian Bevec, Jochen Heukeshoven, et al.. (2005). Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. Journal of Clinical Investigation. 115(1). 76–85. 71 indexed citations
9.
Bevec, Dorian, et al.. (2004). Screening Assay for the Identification of Deoxyhypusine Synthase Inhibitors. SLAS DISCOVERY. 9(5). 434–438. 16 indexed citations
10.
Baghestanian, Mehrdad, John-Hendrik Jordan, Hans P. Kiener, et al.. (2002). Activation of Human Mast Cells through Stem Cell Factor Receptor (KIT) Is Associated with Expression of bcl-2. International Archives of Allergy and Immunology. 129(3). 228–236. 27 indexed citations
11.
Wallasch, Christian, Jean E. Crabtree, Dorian Bevec, et al.. (2002). Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochemical and Biophysical Research Communications. 295(3). 695–701. 106 indexed citations
12.
13.
Bevec, Dorian & Joachim Hauber. (1997). Eukaryotic Initiation Factor 5A Activity and HIV-1 Rev Function. Neurosignals. 6(3). 124–133. 51 indexed citations
14.
Kapiotis, S., Gürkan Sengoelge, Wolfgang R. Sperr, et al.. (1996). Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells. Life Sciences. 58(23). 2167–2181. 52 indexed citations
15.
Bevec, Dorian, Herbert Jaksche, Martin Oft, et al.. (1996). Inhibition of HIV-1 Replication in Lymphocytes by Mutants of the Rev Cofactor eIF-5A. Science. 271(5257). 1858–1860. 180 indexed citations
16.
Bevec, Dorian, Beatrix Volc‐Platzer, Klaus F. Zimmermann, et al.. (1994). Constitutive Expression of Chimeric Neo -Rev Response Element Transcripts Suppresses HIV-1 Replication in Human CD4 + T Lymphocytes. Human Gene Therapy. 5(2). 193–201. 30 indexed citations
17.
Cerwenka, Adelheid, Dorian Bevec, Otto Majdic, Walter Knapp, & Wolfgang Holter. (1994). TGF- beta 1 is a potent inducer of human effector T cells.. The Journal of Immunology. 153(10). 4367–4377. 76 indexed citations
18.
Sillaber, Christian, Dorian Bevec, Joseph H. Butterfield, et al.. (1993). Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.. PubMed. 21(9). 1271–5. 58 indexed citations
19.
Feucht, Helmut E., Jörg Zwirner, Dorian Bevec, et al.. (1989). Biosynthesis of Complement C4 Messenger RNA in Normal Human Kidney. ˜The œNephron journals/Nephron journals. 53(4). 338–342. 37 indexed citations
20.
Robinson, Peter, Dorian Bevec, Andrew L. Mellor, & Elisabeth H. Weiss. (1988). Sequence of the mouse Q4 class I gene and characterization of the gene product. Immunogenetics. 27(2). 79–86. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia E. Rao Breakdown of academic impact, for papers by Kevin L. Holmes Breakdown of academic impact, for papers by Sheryl Brown‐Shimer Breakdown of academic impact, for papers by Ludger Ständker Breakdown of academic impact, for papers by Daniel C. Hoessli Breakdown of academic impact, for papers by Jacques Thèze Breakdown of academic impact, for papers by R. Kurrle Breakdown of academic impact, for papers by Vincent J. Merluzzi Breakdown of academic impact, for papers by Michael K. Hoffmann Breakdown of academic impact, for papers by Thomas Hoffman
Rankless by CCL
2026